Ifabotuzumab Biosimilar – Anti-EPHA3, REK4 mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Applications

,

Product nameIfabotuzumab Biosimilar - Anti-EPHA3, REK4 mAb - Research Grade
SourceCAS 1234137-51-9
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsIfabotuzumab,KB-004,EPHA3, REK4,anti-EPHA3, REK4
ReferencePX-TA1398
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Ifabotuzumab Biosimilar - Anti-EPHA3/REK4 mAb - Research Grade

General information on Anti-EPHA3/REK4[Homo sapiens] (Ifabotuzumab) Monoclonal Antibody

Ifabotuzumab has been investigated for the treatment of Myelodysplastic syndrome, Myelofibrosis and Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Ifabotuzumab Biosimilar – Anti-EPHA3, REK4 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human EPHA3 recombinant protein
Antigen

Human EPHA3 recombinant protein

PX-P6099 395€
Stable Isotope Labelled Ifabotuzumab Biosimilar – Anti-EPHA3/REK4 mAb – Research Grade
SIL

Stable Isotope Labelled Ifabotuzumab Biosimilar – Anti-EPHA3/REK4 mAb – Research Grade

PX-TA1398-SIL 15000€
Ifabotuzumab ELISA Kit
ELISA

Ifabotuzumab ELISA Kit

KPTX218 1300€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products